This topic contains a solution. Click here to go to the answer

Author Question: The anticoagulant of 3.2 sodium citrate is preferred over 3.8 because: a. It does not require an ... (Read 144 times)

ap345

  • Hero Member
  • *****
  • Posts: 537
The anticoagulant of 3.2 sodium citrate is preferred over 3.8 because:
 
  a. It does not require an adjusted redraw on patients with high hematocrits.
  b. The 3.8 sodium citrate tubes are no longer manufactured.
  c. The 3.2 sodium citrate has more success with minimizing in vitro platelet activation.
  d. It is more likely to prevent clotting with difficult draws.

Question 2

Based on the following data, what is the patient's most likely factor deficiency?
 
  PT Prolonged
  APTT Normal
  TT Normal
 
  a. F-II
  b. F-X
  c. F-IX
  d. F-VII



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

flannelavenger

  • Sr. Member
  • ****
  • Posts: 322
Answer to Question 1

Correct Answer: A

Answer to Question 2

Correct answer: D





 

Did you know?

People who have myopia, or nearsightedness, are not able to see objects at a distance but only up close. It occurs when the cornea is either curved too steeply, the eye is too long, or both. This condition is progressive and worsens with time. More than 100 million people in the United States are nearsighted, but only 20% of those are born with the condition. Diet, eye exercise, drug therapy, and corrective lenses can all help manage nearsightedness.

Did you know?

Elderly adults are living longer, and causes of death are shifting. At the same time, autopsy rates are at or near their lowest in history.

Did you know?

About 60% of newborn infants in the United States are jaundiced; that is, they look yellow. Kernicterus is a form of brain damage caused by excessive jaundice. When babies begin to be affected by excessive jaundice and begin to have brain damage, they become excessively lethargic.

Did you know?

Immunoglobulin injections may give short-term protection against, or reduce severity of certain diseases. They help people who have an inherited problem making their own antibodies, or those who are having certain types of cancer treatments.

Did you know?

Your chance of developing a kidney stone is 1 in 10. In recent years, approximately 3.7 million people in the United States were diagnosed with a kidney disease.

For a complete list of videos, visit our video library